Myriad Genetics Inc (MYGN)
- Exchange
- NASDAQ
- Symbol
- MYGN
- Sector
- Life Sciences
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Description
- Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah.
- Country
- USA
Stock price
At close: July 11, 2025
-
Open5.45
-
High5.59
-
Low5.32
-
Close5.34
-
Volume888,124
Financial ratios
Dec 31, 2024